Skip to content

Esketamine: all studies

Page 103 of 123: studies 1,021 to 1,030 of 1,225, newest first. Back to the esketamine overview

Research

Ketamine for unipolar depression: A systematic review of efficacy and safety.

Australasian Psychiatry June 1, 2025 Tharshanan Edwin Peiris, Amrit Pokhrel, Yuvaraj Paudel 2 citations

BackgroundUnipolar depression is a prevalent mental health disorder with persistent, treatment-resistant symptoms. Traditional antidepressants take weeks to show effects, underscoring the need for faster alternatives. Ketamine, originally an anaesthetic, has emerged as a rapid-acting antidepressant.ObjectiveThis systematic review evaluates ketamine's efficacy and safety in unipolar...

Advances in the study of NMDA receptors in depression pathogenesis and the antidepressant efficacy of their antagonists.

Asian Journal of Psychiatry June 1, 2025 Mingrui Chen, Jingyan Jin, Hongsheng Bi et al. 12 citations

N-methyl-D-aspartate receptors (NMDA receptors) play a crucial role as ionotropic glutamate receptors in regulating neuroplasticity, learning, memory, and a range of psychiatric disorders. Studies indicate that dysfunction of NMDA receptors is a key pathological mechanism in depression, where abnormal activation can result in neuronal excitotoxicity, excessive extracellular calcium ion...

DOI: 10.1016/j.ajp.2025.104502 (opens in new tab) Full text (opens in new tab) Antidepressants Glutamatergic Nmda receptor antagonists Nmda receptors +4

Generalizability of Risk Models for Treatment-Resistant Depression Across Three Health Systems.

medRxiv May 27, 2025 Colin G Walsh, Michael Ripperger, Thomas H McCoy et al. preprint

As multiple strategies have emerged for managing treatment-resistant major depressive disorder, efficient identification of individuals at elevated risk for this outcome earlier in their illness course remains essential. We extracted electronic health records data for all individuals with a diagnosis of major depressive disorder who received an index antidepressant prescription in the clinical...

DOI: 10.1101/2025.05.21.25328089 (opens in new tab) Full text (opens in new tab) Depression Treatment resistance Mental health Predictive analytics +1

Potential Antidepressive Effects of R-ketamine in Patients with Treatment Resistance Depression

Carleton undergraduate journal of science. May 16, 2025 Sumika Egner

Ketamine has a long history as an anesthetic but has recently demonstrated antidepressant effects at sub-anesthetic doses (Matveychuk et al., 2020). For individuals with treatment-resistant depression (TRD), typical antidepressants are frequently ineffective, whereas ketamine’s unique mechanisms have demonstrated promising results in reducing depressive symptoms where other treatments have...

N-methyl-d-aspartate receptor hypofunction causes recurrent and transient failures of perceptual inference.

Brain May 13, 2025 Veith Weilnhammer, Marcus Rothkirch, Deniz Yilmaz et al. 11 citations

Perception integrates external sensory signals with internal predictions that reflect prior knowledge about the world. Previous research suggests that this integration is governed by slow alternations between an external mode, driven by sensory signals, and an internal mode, shaped by prior knowledge. Using a double-blind, placebo-controlled, cross-over experiment in healthy human participants,...

DOI: 10.1093/brain/awaf011 (opens in new tab) Full text (opens in new tab) Ketamine Bistable perception Predictive processing Psychosis +6

Understanding and treating postpartum depression: a narrative review.

International Clinical Psychopharmacology May 1, 2025 Vincenzo Cardaci, Matteo Carminati, Mattia Tondello et al. 7 citations

Postpartum depression (PPD) is an increasingly prevalent but still poorly characterized disorder. Causal and modulating factors include hormones fluctuations, such as estrogen, progesterone, and allopregnolone, pathways imbalances, such as oxytocin and kynurenine, chronobiological factors, and brain imaging alterations. Treatment may differ from the traditional major depression management,...

DOI: 10.1097/YIC.0000000000000560 (opens in new tab) Full text (opens in new tab) Postpartum depression ppd Postnatal depression Maternal wellness Behavioral therapy +2

Emerging Viral Infections (ZIKV, SARS-CoV-2, and MPXV) and Depression: Ketamine and (S, R)-Ketamine as Promising Antidepressants.

Reviews in medical virology May 1, 2025 Qianqian Cao, Ning Zhang, Cuibo Leng et al. 1 citation

Emerging viral pathogens, newly reported or rapidly evolving viruses, are a significant public health concern worldwide. Beyond their characteristic clinical presentations, emerging viruses, such as monkeypox virus (MPXV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been increasingly implicated in the development of various neuropsychiatric complications including...

DOI: 10.1002/rmv.70036 (opens in new tab) Full text (opens in new tab) S‐ketamine Emerging viruses Viral-depression Ketamine-therapy +2

New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?

Pharmaceuticals April 30, 2025 Paola Bozzatello, Roberta Novelli, Rebecca Schisano et al. 6 citations

Psychiatric disorders are a major cause of illness in the world. Unfortunately, many patients are resistant to treatment and present serious complications. Schizophrenia is refractory to treatment in about one-third of patients. Antidepressants are effective in about half of patients. Suicidal ideation is an increasing issue in patients with mixed features in bipolar disorder (BD). Therefore,...

DOI: 10.3390/ph18050665 (opens in new tab) Full text (opens in new tab) Anxiety disorders Bipolar disorder Efficacy Major depression +9

Increased sensitivity to psychomotor effects of ketamine enantiomers in the Wistar-Kyoto depression model.

Journal of Psychiatric Research April 1, 2025 Kristian Elersič, Anamarija Banjac, Marko Živin et al. 3 citations

Ketamine, a fast-acting antidepressant, is a racemic mixture, composed of equal amounts of R- and S-ketamine. Preclinical studies are comparing them to better understand their role in therapeutic and undesirable effects. An important research gap is that studies do not use long clinically relevant protocols to compare the desired and undesired effects of ketamine enantiomers in modeled and...

DOI: 10.1016/j.jpsychires.2025.02.061 (opens in new tab) Full text (opens in new tab) Depressive disorder Depression mood disorder Clinical depression Ketamine ketalar +10

Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.

Cureus April 1, 2025 Ciara Mimms, Kassandra Sotelo, Abdul Saboor Khaliq 1 citation

This systematic review explores the comparative efficacy and functional outcomes of psychedelic-assisted therapies in the management of treatment-resistant depression (TRD). Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive literature search was conducted across PubMed, Scopus, and Web of Science for randomized controlled...